DaShenLin Pharmaceutical Group Co., Ltd.

SHSE:603233 Stock Report

Market Cap: CN¥17.4b

DaShenLin Pharmaceutical Group Dividends and Buybacks

Dividend criteria checks 4/6

DaShenLin Pharmaceutical Group is a dividend paying company with a current yield of 4.05% that is well covered by earnings.

Key information

4.1%

Dividend yield

0.005%

Buyback Yield

Total Shareholder Yield4.1%
Future Dividend Yield2.6%
Dividend Growth25.6%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per shareCN¥0.620
Payout ratio83%

Recent dividend and buyback updates

No updates

Recent updates

Take Care Before Diving Into The Deep End On DaShenLin Pharmaceutical Group Co., Ltd. (SHSE:603233)

Sep 30
Take Care Before Diving Into The Deep End On DaShenLin Pharmaceutical Group Co., Ltd. (SHSE:603233)

DaShenLin Pharmaceutical Group Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models

Sep 03
DaShenLin Pharmaceutical Group Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models

DaShenLin Pharmaceutical Group (SHSE:603233) May Have Issues Allocating Its Capital

Aug 20
DaShenLin Pharmaceutical Group (SHSE:603233) May Have Issues Allocating Its Capital

Not Many Are Piling Into DaShenLin Pharmaceutical Group Co., Ltd. (SHSE:603233) Stock Yet As It Plummets 27%

Jun 17
Not Many Are Piling Into DaShenLin Pharmaceutical Group Co., Ltd. (SHSE:603233) Stock Yet As It Plummets 27%

Does DaShenLin Pharmaceutical Group (SHSE:603233) Have A Healthy Balance Sheet?

Jun 09
Does DaShenLin Pharmaceutical Group (SHSE:603233) Have A Healthy Balance Sheet?

Are Investors Undervaluing DaShenLin Pharmaceutical Group Co., Ltd. (SHSE:603233) By 30%?

May 21
Are Investors Undervaluing DaShenLin Pharmaceutical Group Co., Ltd. (SHSE:603233) By 30%?

Some May Be Optimistic About DaShenLin Pharmaceutical Group's (SHSE:603233) Earnings

May 06
Some May Be Optimistic About DaShenLin Pharmaceutical Group's (SHSE:603233) Earnings

Investors Could Be Concerned With DaShenLin Pharmaceutical Group's (SHSE:603233) Returns On Capital

Apr 09
Investors Could Be Concerned With DaShenLin Pharmaceutical Group's (SHSE:603233) Returns On Capital

Lacklustre Performance Is Driving DaShenLin Pharmaceutical Group Co., Ltd.'s (SHSE:603233) Low P/E

Mar 17
Lacklustre Performance Is Driving DaShenLin Pharmaceutical Group Co., Ltd.'s (SHSE:603233) Low P/E

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: 603233 has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: 603233's dividend payments have increased, but the company has only paid a dividend for 6 years.


Dividend Yield vs Market

DaShenLin Pharmaceutical Group Dividend Yield vs Market
How does 603233 dividend yield compare to the market?
SegmentDividend Yield
Company (603233)4.1%
Market Bottom 25% (CN)0.5%
Market Top 25% (CN)2.1%
Industry Average (Consumer Retailing)1.9%
Analyst forecast (603233) (up to 3 years)2.6%

Notable Dividend: 603233's dividend (4.05%) is higher than the bottom 25% of dividend payers in the CN market (0.53%).

High Dividend: 603233's dividend (4.05%) is in the top 25% of dividend payers in the CN market (2.08%)


Earnings Payout to Shareholders

Earnings Coverage: At its current payout ratio (82.8%), 603233's payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: With its reasonably low cash payout ratio (47.5%), 603233's dividend payments are well covered by cash flows.


Discover strong dividend paying companies